Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 172

The DOI matches its Crossref record.

Enzyme therapy for Pompe disease with recombinant human α‐glucosidase from rabbit milk

Van den Hout, J. M. P., Reuser, A. J. J., de Klerk, J. B. C., Arts, W. F., Smeitink, J. A. M., Van der Ploeg, A. T. · 2001 · Journal of Inherited Metabolic Disease

Abstract

Pompe disease is a metabolic myopathy caused by deficiency of lysosomal acid α‐glucosidase. In this report we review the first 36 weeks of a clinical study on the safety and efficacy of enzyme therapy aimed at correcting the deficiency. Four patients with infantile Pompe disease were enrolled. They received recombinant human α‐glucosidase from transgenic rabbit milk. The product is generally well tolerated and reaches the primary target tissues. Normalization of α‐glucosidase activity in skeletal muscle was obtained and degradation of PAS‐positive material was seen in tissue sections. The clinical condition of all patients improved. The effect on heart was most significant, with an impressive reduction of the left ventricular mass index (LVMI). Motor function improved. The positive preliminary results stimulate continuation and extension of efforts towards the realization of enzyme therapy for Pompe disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1023/a:1010383421286

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 172

Metadata

Authors
Van den Hout, J. M. P., Reuser, A. J. J., de Klerk, J. B. C., Arts, W. F., Smeitink, J. A. M., & Van der Ploeg, A. T.
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
2001-04
Volume
24
Issue
2
Pages
266-274
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W1508384479
Cited by
172
References
0
FWCI
8.66
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enzyme therapy for Pompe disease with recombinant human α‐glucosidase from rabbit milk. https://app.cochat.ai/papers/10.1023/a:1010383421286
The paper
Van den Hout, J. M. P., Reuser, A. J. J., de Klerk, J. B. C., Arts, W. F., Smeitink, J. A. M., & Van der Ploeg, A. T. (2001). Enzyme therapy for Pompe disease with recombinant human α‐glucosidase from rabbit milk. Journal of Inherited Metabolic Disease. https://doi.org/10.1023/a%3A1010383421286

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.